The results indicated that high expression of EDEM1 was prominently associated with ER status and PR status in breast cancer (P < 0.001), indicating a potential role of EDEM1 in breast cancer progression, especially TNBC progression (Table S1). Here, ESR1 is linked to breast carcinoma.